Skip to main content
OceansBio Co., Ltd. logo

OceansBio Co., Ltd. — Investor Relations & Filings

Ticker · 332190 ISIN · KR7332190008 KO Manufacturing
Open in API
Filings indexed 35 across all filing types
Latest filing 2025-08-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 332190

About OceansBio Co., Ltd.

https://oceansbio.com/

OceansBio Co., Ltd. is a medical technology company that develops and manufactures electroceuticals, or electronic medicines, to treat neurological diseases. The company's core technology is vagus nerve stimulation (VNS), which it applies through both wearable (extracorporeal) and implantable devices. Its flagship product, TaVNS, is a wearable electrical stimulation device designed for patients with conditions such as epilepsy and depression. OceansBio integrates artificial intelligence (AI) into its medical devices to provide personalized treatment solutions.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for OceansBio Co., Ltd. It includes the meeting date, location, agenda items (appointment/resignation of directors), and management reference materials (경영참고사항) such as director activity reports and business overviews. This is a standard proxy solicitation document sent to shareholders to inform them of an upcoming meeting and request their votes.
2025-08-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for '오션스바이오'. It details the date, time, location, and specific agenda items, including the appointment and resignation of directors. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2025-07-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM). It specifies the record date (2025-07-30) and the purpose (holding an EGM on 2025-08-29). This type of regulatory disclosure regarding shareholder meetings and record dates is standard for corporate governance and does not fit into specific report categories like 10-K or IR, nor is it a simple report publication announcement. It falls under general regulatory filings.
2025-07-15 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) presentation held by Oceans Bio. It provides details such as the date, location (online platforms), attendees, and a summary of the topics covered. Since it is a short announcement confirming that an IR event took place and where the materials can be found, rather than the presentation slides themselves, it falls under the category of a regulatory filing announcement regarding an IR event.
2025-06-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (specifically, the resignation of an executive leading to a change in special relationship status). This type of filing is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2025-04-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the shareholding changes of an executive (Kang Guiyeom) due to resignation. In the context of financial filings, reports regarding personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2025-04-04 Korean

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.